EU Dental Amalgam Ban Forces a Rapid Shift in Restorative Dentistry
By January 2025, dental amalgam was no longer permitted for routine use across the European Union. The phase-out arrived five years earlier than many in dentistry had expected, and it immediately shifted the balance between a material that has anchored posterior restorative care for generations and the cleaner, tooth-coloured alternatives now moving into the foreground. The ban applies to use and export, with exceptions only for specific medical needs and cases judged strictly necessary by a medical practitioner.
The decision did not emerge in a vacuum. Mercury has long carried a heavy toxicological burden, and amalgam has always sat at the uncomfortable intersection of clinical utility and environmental concern. The ban reflects both pressures at once: public health protection and a requirement to reduce mercury contamination in the wider environment.
Why Amalgam Was Phased Out After More Than 175 Years
Amalgam has been used in dentistry for more than 175 years. The material is built from two halves: liquid mercury and a powdered alloy of silver, tin and copper. Its appeal was straightforward. It was strong, durable, relatively inexpensive, and easy to place, which made it the default restorative material for posterior teeth across large parts of the world.
Yet controversy followed it from the beginning. Concerns about mercury toxicity surfaced in the nineteenth century, and those concerns never fully disappeared. Today, the biological argument against routine use is no longer abstract. Mercury vapour can be highly toxic when inhaled, and exposure has been associated with kidney problems, nervous system damage, skin problems, neurological and behavioural disorders, and effects on the immune system. Foetal exposure is a particular concern. In clinical terms, the shift away from amalgam is a response to a material that can work well in the mouth while creating avoidable exposure risks elsewhere in the chain of care.
There is also a practical inflection point in modern dentistry. Composite and other tooth-coloured restorative materials have improved substantially, and many clinicians now see them as more compatible with contemporary minimally invasive dentistry. They preserve more tooth tissue during preparation and offer far better aesthetics. Amalgam still has advantages in strength and durability, but the trade-off now looks harder to justify in settings where safer and more acceptable alternatives can be used effectively.
Mercury Exposure, Practice Safety, and the Material’s Limits
The greatest risk to patients and staff arises during placement and removal, not from a stable filling left undisturbed in the mouth. For that reason, intact amalgam restorations are generally safer left in place unless they are damaged, defective, or clearly linked to local symptoms. When close contact with skin or mucous membranes occurs, mercury can provoke allergic skin inflammation, and some patients develop gum inflammation or painful oral ulcers. In some cases, facial inflammation appears as part of the same pattern. Removal usually resolves those reactions.
One sentence matters in daily practice: unnecessary removal can do more harm than leaving a sound restoration untouched.
For staff, the issue is cumulative exposure. Small doses over time can be harmful, so practice-level controls remain essential. Amalgam is mixed in pre-dosed capsules using an amalgamator rather than the old pestle-and-mortar method, which reduces handling risk. Personal protective equipment is required during removal, unused capsules and waste must go into lidded amalgam pots, and any residue on instruments should be cleared before sterilisation to prevent build-up in the steriliser. Waste handling is regulated as a separate stream because amalgam is a mercury-containing hazardous material.
What UK Dentistry Still Has to Work Around
In the UK, amalgam remains the most common material for NHS permanent fillings, especially in posterior teeth where strength and cost have historically made it the default option. That matters because fillings account for a substantial share of NHS treatment in England, and amalgam still occupies a significant proportion of those procedures. When a familiar restorative material exits the system, the effect is not limited to materials science. It reaches chairside workflow, procurement, training, treatment planning, and NHS capacity.
Current regulations already limit how amalgam can be used. It must be supplied in pre-dosed encapsulated form, bulk mercury is prohibited, and dental practices must have amalgam separators capable of retaining at least 95% of particles. It should not be used for deciduous teeth in children under 15 years or in pregnant or breastfeeding women, except when a practitioner judges it strictly necessary for specific medical needs. These restrictions show how heavily practice has already been narrowed before the full EU phase-out.
The profession’s response in the UK has been mixed but forceful. Some clinicians welcome a move away from mercury-containing restorations and see the ban as overdue. Others warn that a rapid phase-out collides with the financial and operational pressure already borne by NHS dentistry. When a low-cost restorative option disappears, practices with limited margins face higher material costs and potentially longer appointments, especially if they shift more heavily to composite or lab-made restorations.
Environmental Pressure Helped Drive the Ban
Environmental concerns strengthened the case for removal. The main sources of mercury pollution linked to dentistry are wastewater from surgeries and emissions from crematoria. Amalgam separators can remove about 95% of amalgam particles from clinical wastewater, but their reach has been uneven globally, and many countries have only introduced them recently or not at all. Crematoria flue filters reduce atmospheric release, but they do not remove the basic problem that mercury is entering the environment through repeated human use.
The carbon argument is more complicated than a simple swap from one material to another. Amalgam manufacturing carries a larger carbon footprint than resin-based composite or glass ionomer materials, but alternatives also have environmental costs across production, distribution, use and disposal. There is no zero-impact restorative material. The relevant clinical question is which option delivers durable oral rehabilitation with the least human and environmental harm across its full life cycle.
The Wider Regulatory Question for the UK
The EU ban places the UK in an awkward position. Dental trade does not stop neatly at a border, and supply chains can be affected even when domestic law does not mirror the EU exactly. The practical consequences may include altered procurement routes, pressure to align restorative policy with European standards, and more urgent discussion about how NHS dentistry will absorb the loss of one of its most economical posterior restorative materials.
A global phase-out date of 2034 was also agreed at the Sixth Conference of the Parties to the Minamata Convention on Mercury, with an exemption allowing use when a dental practitioner judges it necessary for the patient’s needs. That creates an important clinical boundary: amalgam is moving from routine restorative work toward a narrowly defined exception.
For UK dentistry, the unresolved issue is not whether the material is disappearing from mainstream practice. It is how quickly the system can replace it without widening access gaps, increasing treatment delays, or pushing practices toward options that are clinically sound but financially harder to deliver at scale.